Close
Visualize HL7 Example and Test Instances (vi7eti), pronounced /viːˈsɛtiː/
Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on medicines. The web pages are not kept up to date and are for demonstration purposes only. For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine.
Show source BACK TO LIST

Laboratory Report

Patient
Name: Rijneveld, Eliane
DOB: 25-FEB-1969 (Age: 56)
Gender: female
Address:
Taille Maréchal 477
1083 Ganshoren (Belgium)
ID: 6132-571926-0
Report
Date: 18-NOV-2023
Laboratory
Requested by
Ziekenhuis Inkendaal
1600 Sint-Pieters-Leeuw (Belgium)
Specimen
Collected: 17-NOV-2023

This seems not to be an HL7 Europe Laboratory Report (type coding LOINC 11502-2)

Chemistry

Test 17 Nov 2023 Reference Range Unit
Hemoglobin A1c/Hemoglobin.total in Blood 6.4 H 4.8 - 5.7 %
Glucose [Mass/volume] in Blood 70.9 70 - 99 mg/dL
Urea nitrogen [Mass/volume] in Blood 19.2 7 - 50 mg/dL
Creatinine [Mass/volume] in Blood 0.9 0.6 - 1.1 mg/dL
Calcium [Mass/volume] in Blood 8.9 8.5 - 10.5 mg/dL
Sodium [Moles/volume] in Blood 141.3 135 - 145 mmol/L
Potassium [Moles/volume] in Blood 4.9 3.5 - 5.1 mmol/L
Chloride [Moles/volume] in Blood 106.1 98 - 114 mmol/L
Carbon dioxide, total [Moles/volume] in Blood 28.5 22 - 32 mmol/L

Annotation

Conclusion and Recommendations based on this report and previous findings known to us
The patient shows a persistently elevated HbA1c (now 6.4%), indicating poor glycemic control and likely diabetes. Other parameters, including renal function, electrolytes, and calcium, are within normal limits. No acute metabolic or renal disturbances are evident. Recommend clinical follow-up for diabetes management and monitoring of glycemic control.